GlassScriptPhysician profile
Dana Scott
NPI 1154945178
$1,122.72
in general payments reported to CMS, 2019-2025
18 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $32.94 · 2023: $375 · 2024: $251 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.20 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $328.11 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Menarini Silicon Biosystems, INC. | $145.74 | 2024 | |
| Incyte Corporation | $118.59 | 2021 | |
| Abbvie INC. | $86.37 | 2025 | |
| Janssen Pharmaceuticals, INC | $67.61 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $66.00 | 2023 | |
| Boston Scientific Corporation | $58.29 | 2023 | Avvigo Guidance System, Opticross |
| Takeda Pharmaceuticals U.S.A., INC. | $54.68 | 2024-2025 | Ninlaro |
| Edwards Lifesciences Corporation | $28.54 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Regeneron Pharmaceuticals, INC. | $24.92 | 2025 | Lynozyfic |
| Karyopharm Therapeutics INC. | $24.40 | 2025 | Xpovio |
| Alnylam Pharmaceuticals INC. | $22.96 | 2023 | Onpattro |
| Surmodics, INC. | $19.05 | 2022 | |
| Pfizer INC. | $17.95 | 2023 | |
| Genzyme Corporation | $15.71 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $15.26 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Tempus Ai, INC | $14.65 | 2025 | Xt Cdx |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.